4.7 Review

Osthole: An up-to-date review of its anticancer potential and mechanisms of action

期刊

FRONTIERS IN PHARMACOLOGY
卷 13, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2022.945627

关键词

osthole; anticancer; proliferation; apoptosis; metastasis; angiogenesis; chemotherapy; multidrug resistance

资金

  1. Liaoning Science and Technology Plan Project [2021JH2/10300118]
  2. Shenyang Science and Technology Innovation Talent Support Program for Youth and Midlife [RC200121]
  3. 345 Talent Project Program of China Medical University Shengjing Hospital [2019-40A]

向作者/读者索取更多资源

Cancer is a global health problem with high incidence and mortality rates. Osthole, a coumarin compound extracted from Cnidium monnieri (L.) Cuss., has shown promising anticancer effects. Studies have revealed that osthole inhibits cancer cell proliferation, induces apoptosis, suppresses migration and invasion, inhibits angiogenesis, enhances sensitivity to chemotherapy drugs, and reverses multidrug resistance.
With its high incidence and mortality rates, cancer is one of the largest health problems worldwide. Investigating various cancer treatment options has been the focus of many domestic and international researchers, and significant progress has been made in the study of the anticancer effects of traditional Chinese medicines. Osthole, a coumarin compound extracted from Cnidium monnieri (L.) Cuss., has become a new research hotspot. There have been many reports on its anticancer effects, and recent studies have elucidated that its underlying mechanism of action mainly involves inhibiting cancer cell proliferation, inducing cancer cell apoptosis, inhibiting invasion and migration of cancer cells, inhibiting cancer angiogenesis, increasing sensitivity to chemotherapy drugs, and reversing multidrug resistance of cancer cells. This mini-review summarizes the research progress on the anticancer effects of osthole in recent years.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据